Issue 17, 2022

Charge reversal hairpin peptide modified synergy therapeutic nanoplatforms for tumor specific drug shuttling

Abstract

Given the distinct pathological features of neoplasm tissues, multifunctional responsive nanocarriers have been recently considered as promising candidates to optimize the chemotherapy regime. As a result, we propose a graphene oxide-based pH-responsive drug delivery system via covalent assembly of “hairpin-like” cell penetrating peptides with acid sensitive and charge reversal properties to realize superior tumor specificity and lower toxicity. Graphene oxide here can serve as high doxorubicin-loading nanosheets and facilitate swift drug release in response to laser irradiation, which provides an efficient platform for the synergy of photo-chemotherapy. Structurally, polyglycol conjugation on the graphene oxide surface fulfils the function of nanocomposite stabilization. After administration, the elaborately acid sensitive cell penetrating peptides maintain the hairpin structure under physiological conditions, while after entering the tumor acidic microenvironment, they undergo charge reversal and structural conversion to promote the cellular uptake of nanoparticles. The evaluation of nanocomposites in vitro revealed their negligible systematic toxicity and remarkable antitumor effects. In vivo experiments also confirmed the impressive stability and tumor-specific targeting for alleviating breast cancer. In conclusion, hairpin peptide modified graphene oxide nanoparticles show multiple merits including high drug carrying capacity, selective tumor penetration, responsive drug release and effective combination oncotherapy.

Graphical abstract: Charge reversal hairpin peptide modified synergy therapeutic nanoplatforms for tumor specific drug shuttling

Supplementary files

Article information

Article type
Paper
Submitted
24 May 2022
Accepted
13 Jul 2022
First published
13 Jul 2022

Biomater. Sci., 2022,10, 4889-4901

Charge reversal hairpin peptide modified synergy therapeutic nanoplatforms for tumor specific drug shuttling

Z. Fan, Z. Ji, F. Zhang, P. Luo, H. Zhang, J. Zhou, H. Cheng and Y. Ding, Biomater. Sci., 2022, 10, 4889 DOI: 10.1039/D2BM00817C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements